abstract |
The present invention provides a chimeric prostate-homing peptide with pro-apoptotic activity. In a preferred embodiment, the chimeric prostate-homing pro-apoptotic peptide contains the sequence SMSIARL-GG- D (KLAKLAK) 2 . Methods of using such chimeric peptides for treating patients having prostate cancer also are provided. |